Shreefal Mehta, Ph.D. MBA

For formatted resume, click here to get pdf format or MS Word format

 

AREAS OF ACTIVITY

      Biotechnology Entrepreneurship and Management seminars at RPI

      Radical Innovation Management Research                Economic Development reports

      Cytopia               

New BOOK - "Commercializing Successful Biomedical Technologies:
Basic Principles for the Development of Drugs, Diagnostics and Devices" available May 2008

SELECT RECENT PUBLICATIONS, COURSES

Journal Publication: Nature Biotechnology,: December 2004: Paths to entrepreneurship in life sciences (pdf file)

Journal Publication: Nature Biotechnology January 2004: Emerging role of academia in commercializing innovation (pdf file)

Online Publication: What Will it Take for a Capital Region Biotechnology Cluster to Grow and Sustain Itself? (html link)

Journal Publication: Pharmaceuticals, Biotechnology and the Bayh-Dole Act (pdf file)

Paper by my colleague Raj Bawa on Nanotechnology patenting - click here

Course: Commercializing Biomedical Technologies: For Scientists, Engineers and MBA students (click for syllabus)

Topics for papers in progress: Nanobiotechnology business models;
                                                  Radical innovation in market leading companies;
                                                  Evaluating economic development in the energy industry - a case of business models and value chains;
                                                  The competitive landscape and strategy for pharmaceutical and biotech industry.

RESUME:

                                          Shreefal Mehta, Ph.D. MBA

198 Pawling Ave #26, Troy NY 12180       email:  shreefal@scientist.com               Fax: 509-267-3513   Cell: 518-331-8078

 

                                                                         EXPERIENCE                                                                          

Entrepreneurship, business development, finance and marketing

CEO and co-founder:  Myomatrix Therapeutics                                                            January 2001 – present

Grew cardiovascular pharmaceutical startup from concept to 4 product development projects currently in progress.
Human Resource
management         Myomatrix currently has 5 employees (founders, full time, part time and contract)

Financing:                   Successful seed round of over $500,000 in debt and equity financing. Preparation of business plan, financial projections and planning, presentations to venture capitalists. Accounting, payroll systems, CFO functions.  

Business Development: Experience in negotiating a co-development (50% cost sharing) contract with a large multinational pharmaceutical company; in-licensed technology from companies and universities, established R&D collaborations. Currently in partnering talks with Australian biotechnology company.

Science:                       Identified and evaluated technologies for in-licensing or partnership; completed 5 SBIR proposals to NSF/NIH/NASA to help fund technology development in the company’s drug discovery platform technologies and products. 

  

Program Director, Radical Innovation Research Program , RPI July 2003 - present

Worked with VP-level executives in market-leading companies and with management faculty to further grow a management research program in sustaining corporate innovation capabilities in large multinational corporations. Successfully recruited a new cohort (cohort III) of companies including Procter and Gamble, Guidant, Dow Corning, Rohm and Haas, PPG Industries, Xerox, and Intel. Organized and participated in executive-level workshop/conference with thought leaders and top level innovation managers from these companies.

 

Research Assistant Professor of Biotechnology Management , RPI November 2001 - present
Research Assistant Professor of Biomedical Engineering (joint appointment) November 2003- present

 

Marketing Research Analyst: X-Ray Optical Systems, Inc. in Albany, NY                               Summer 2001

§   developed strategy for successful new product launch into the petrochemical industry; 
§   prepared marketing plan, market research and analysis, 
§   participated in strategy discussions with management and wrote business plan for entry into new markets, 
§   made contacts that resulted in selection of beta test sites, 
§   represented company in National Commercialization Summit organized by DawnBreaker organization under Dept of Energy program. §   worked directly with VP of Marketing and CEO of company.

 

Scientific:  

Faculty member at University of Texas Southwestern Medical Center (UTSW), Dallas TX   1990-2000
Assistant Professor, Department of Radiology  UTSW                                             1995-2000

•  Phase II/III clinical trial experience : data collection, compilation and presentation through participation in a university-sponsored osteoporosis drug trial at UTSW.
•  Research specialization in bone metabolism, extracellular matrix, biomechanics and ultrasound physics and imaging.
•  Managed a research team of research engineers and students, training and supervising a $350,000 operation.
•  Designed and developed a novel ultrasonic device for clinical applications.
•  Published peer-reviewed papers in international scientific journals, presented at international conferences.
•  Developed biochemical and biomechanical methods for the study of bone matrix physiology
•  Collaborated with colleagues in development of novel radiological imaging technologies PET/MR/Ultrasound 

Graduate Research Assistant  UTSW                                                                        1990-1995

·   Conceptualized, proposed and founded a tissue engineering laboratory to investigate the effects of drugs on bone material, with an annual budget of $125,000 and supervised two other graduate students.
·   This effort resulted in a Young Investigator of the Year award (Texas Mineralized Society, 1993) and an interview on a television news channel in Dallas, Texas. Later work focused on biomechanics of bone and a novel ultrasound device developed for clinical use.
·   Developed a novel biodegradable mineralized biopolymer as a bone substitute (Rutgers University). 1989.   
                                                                     EDUCATION                                                                          

Lally School of Management and Technology, Rensselaer Polytechnic Institute, Troy NY             2002
MBA.  Major in technological entrepreneurship and finance.

University of Texas Southwestern Medical Center, Dallas TX:   Ph.D. in Biomedical Engineering              1995

Rutgers University, New Brunswick, NJ:            M.S. in Biomedical Engineering                                     1993

University of Texas at Austin, Austin TX:           B.S. in Mathematics                                                      1990

 

                                                                HONORS, AWARDS                                                                  

§  Invited reviewer on NSF Biotechnology Commercialization SBIR panel 2004-present

§  Member of Steering Committee for Regional Biotechnology Development Association-Bioconnex. 2003- present.

§  Invited panelist on regional conferences on Biotechnology and Business 2002-current. 

§   Awarded Colicchio internship (summer 2001) in Rensselaer Entrepreneurship Interns Program. 

§   Won Lucent-Rensselaer Student Business Plan Competition, 2001.

§   Awarded Bozzone Fellowship at the Lally School of Management and Technology, RPI, 2000-2001.

§   Invited speaker for world-renowned Heiland Lecture Series at Colorado School of Mines, 1998.

§   Young Clinical Investigator Award - General Clinical Research Ctr, UTSW, 1998.

§   Over 25 publications: papers in international journals; book chapters and abstracts 

  

                                                         QUALIFICATIONS SUMMARY                                                      

Management Finance, business plan creation, marketing, business development, R&D management. Resourceful and innovative in meeting goals.

Technical:     Biomechanical, biochemical and biophysical techniques, statistical analysis, PC-based instrumentation. Development of novel approaches to approach complex problems.

Language:    French, Hindi, Gujarati.

Other:           Demonstrable success in written and oral communication. Founder and volunteer in cultural organizations.

 

                                                              REFERENCES                                                                          

1.                  James Mullen, CEO and Chairman of Biogen Inc. 

2.                  Rajesh Shrotriya, CEO and Chairman of Spectrum Pharmaceuticals, Inc

3.                  William Stitt, Professor at Babson University.

4.                  David Ranney, Founder of Access Pharmaceuticals, Director of Global Biomedical Solutions

Contact information for references available on request.

 

FOR DETAILS ON DEALS /LICENSING EXPERIENCE, CLICK HERE to send request.

HOMEPAGE    Affiliations     BioEntrepreneurship    Biotechnology    Biodata       Resume (1pg pdf)  

 

To contact me, please send email to shreefal@scientist.com